Testicular Cancer - Results from #20

Incidence of Erectile Dysfunction and Testosterone Deficiency in Testicular Cancer Survivors. October 2, 2024

Radiological Assessment of Different Retroperitoneal Lymph Node Measurements in Stage 1 Testicular Cancer Patients: Impact on Clinical Stage and Treatment. September 30, 2024

Expression of Heat Shock Protein 90 in Testicular Cancer: A Retrospective Cohort Study. September 27, 2024

Long-term Clinical Outcomes of Patients With Negative Pathology (pN0) at Primary Retroperitoneal Lymph Node Dissection. September 25, 2024

First Indicator of Relapse in Testicular Cancer and Implications for Follow-up: Analysis of the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS). September 23, 2024

Aging-related biomarkers in testicular cancer survivors after different oncologic treatments. September 23, 2024

The expression of programmed cell death ligand 1 (PD-L1) involves in the clinicopathologic characteristics and prognostic implications of testicular germ cell tumor (TGCT): a systematic review and meta-analysis. September 20, 2024

Incidental testicular germ cell tumor in a transgender woman: A case report. September 18, 2024

Testicular cancer malpractice trends. September 18, 2024

Perioperative Serum MicroRNA 371a-3p and 372-3p Levels in Patients with Clinically Localized Testicular Masses. September 16, 2024

Primary retroperitoneal lymph node dissection in testicular germ cell cancer in clinical stage IIA/B-renaissance of an established treatment?. September 16, 2024

Cut-offs for relapse detection in men with stage I testicular germ cell tumors during active surveillance within a prospective multicentre cohort study using either raw or housekeeper normalized miR-371a-3p serum levels. September 13, 2024

Phosphokinases related to drug resistance in two cohorts from the cancer genome atlas (TCGA): uterine carcinoma and testicular cancer. September 12, 2024

Lymph node density as a prognostic marker of relapse in patients who underwent primary retroperitoneal lymph node dissection. September 12, 2024

Financial distress in testicular cancer survivors and its impact on cancer survivors´ quality of life in the German health care system. September 11, 2024

Conventional versus high-dose salvage chemotherapy for relapsed testicular germ cell tumours. September 11, 2024

Efficacy and Safety of Testosterone Replacement in Testicular Cancer Survivors With Treatment-Influenced Hypogonadism: A Systematic Review. September 9, 2024

Association between low total serum testosterone and body mass index in Australian survivors of testicular cancer: a retrospective analysis. September 4, 2024

Evaluation and Management of Testicular Cancer After Late Relapse. September 2, 2024

Understanding the role of endocrine disrupting chemicals in testicular germ cell cancer: Insights into molecular mechanisms. September 2, 2024

Page 2 of 95